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Abstract
Background: Study on long non-coding RNAs (lncRNAs) has been promoted by high-throughput RNA sequencing
(RNA-Seq). However, it is still not trivial to identify lncRNAs from the RNA-Seq data and it remains a challenge to
uncover their functions.
Results: We present a computational pipeline for detecting novel lncRNAs from the RNA-Seq data. First, the genome-
guided transcriptome reconstruction is used to generate initially assembled transcripts. The possible partial transcripts
and artefacts are ﬁltered according to the quantiﬁed expression level. After that, novel lncRNAs are detected by further
ﬁltering known transcripts and those with high protein coding potential, using a newly developed program called
lncRScan. We applied our pipeline to a mouse Klf1 knockout dataset, and discussed the plausible functions of the
novel lncRNAs we detected by diﬀerential expression analysis. We identiﬁed 308 novel lncRNA candidates, which have
shorter transcript length, fewer exons, shorter putative open reading frame, compared with known protein-coding
transcripts. Of the lncRNAs, 52 large intergenic ncRNAs (lincRNAs) show lower expression level than the protein-coding
ones and 13 lncRNAs represent signiﬁcant diﬀerential expression between the wild-type and Klf1 knockout conditions.
Conclusions: Our method can predict a set of novel lncRNAs from the RNA-Seq data. Some of the lncRNAs are
showed diﬀerentially expressed between the wild-type and Klf1 knockout strains, suggested that those novel lncRNAs
can be given high priority in further functional studies.
Background
The category of long non-coding RNAs (lncRNAs) is com-
posed of non-coding RNAs (ncRNAs) with long transcript
length (> 200 nucleotides) [1]. The lncRNAs may carry
out a variety of functions, e.g. scaﬀolding multiple pro-
teins to form a complex, and regulating gene expression
[2-11], however, most lncRNAs’ functions remain to be
speciﬁed. During the past decade, a growing number of
newly detected lncRNAs have been reported thanks to
the development of relevant biotechnology and compu-
tational methods [4,12-16]. Early tiling microarrays were
used to detect the lncRNAs in the mammalian transcrip-
tome [4,5], however, they could not detect precise gene
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structures and exon linkages of the lncRNAs [14]. Sub-
sequently, this problem was tackled by high-throughput
RNA sequencing (RNA-Seq), which presented its advan-
tage of revealing the whole transcriptome [17], including
detailed gene structures and expression levels. So far, the
RNA-Seq has been the major biotechnology for lncRNA
study [13]. For example, by using RNA-Seq, Guttman et al.
[14] obtained detailed information of over a thousand
large intergenic ncRNAs (lincRNAs) in three mouse cell
types [14].
However, studying lncRNAs based on RNA-Seq
encounters several technical problems. First, the assem-
bled transcriptome may include partial transcripts and
artefacts caused by RNA-Seq problems, such as low
sequencing depth, sequencing biases [18] and short
read alignment errors [19]. For lowly expressed tran-
scripts, the sequencing biases may introduce undesired
gaps in the assembly, resulting in partially assembled
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transcripts [20], which may be mistakenly identiﬁed as
lncRNAs. The similar mistakes could also be introduced
by low sequencing depth for lowly expressed transcripts.
Moreover, the incomplete and erroneous assemblies
can aﬀect downstream analysis [21,22]. Second, tran-
scriptome reconstruction [23] based on RNA-Seq reads
may produce a variety of transcripts, e.g. completely
assembled transcripts, intronic RNAs [24] and antisense
transcripts [16], which are classiﬁed by comparing to the
known gene annotations. Thus it is not trivial to identify
lncRNAs from such complex assemblies. Third, it is still
diﬃcult to distinguish the lncRNAs from the protein-
coding mRNAs [1] or short peptides. A protein-coding
mRNA can be deﬁned by open reading frame (ORF)
greater than 100 amino acids (aa) or 300 nucleotides
(nt) [25], but this is arbitrary and incorrect [26]. Here
we present a computational pipeline to address these
problems.
Although thousands of lncRNAs have been identiﬁed
[13,14,16], only a handful of them were functionally char-
acterized. Given the diﬃculty to experimentally charac-
terize the biological functions of the lncRNAs [7], and
given the growing body of genomics and epigenomics
data becoming available relevant to lncRNAs’ biological
functions, it is interesting to predict lncRNAs’ functions
computationally. We applied our computational method
to an RNA-Seq dataset derived from a Klf1 gene knock-
out study on mouse fetal liver tissue [27]. Previous studies
based on the Klf1 knockout study manifested that Klf1
is the founding member of a family of 17 transcription
factors in mammals [28]. Klf1 knockout mice die from
anemia by embryonic day 15 (E15), with severe defects
in diﬀerentiation, hemoglobinization, enucleation, and
membranecytoskeleton organization of red blood cells
[29]. However, very little is known of the lncRNAs reg-
ulated by Klf1 or that participate in the development of
erythroid cells. Here, we recruit the diﬀerential expression




The RNA-Seq dataset for the Klf1 knockout experiment
on mouse embryonic day 14.5 (E14.5) fetal liver tissue
can be obtained from NCBI Gene Expression Omnibus
(GEO) [30] database with accession number GSE33979
[27], and it includes 6 replicates (3 for wild-type and 3
for Klf1 knockout) totalling 160 million 76-base single-
end reads generated by Illumina GAIIx sequencing on
polyadenylated selected (Poly-A+) RNAs. Bowtie [31]
index ofMus musculus genome (mm9), Ensembl [32] and
NCBI reference sequences (RefSeq) mouse gene anno-
tations [33] are all available on Cuﬄinks’ website [34].
University of California Santa Cruz (UCSC)mouse known
gene annotations [35] can be downloaded from the UCSC
genome browser [36].
Pipeline for predicting novel lncRNAs
There are two parts in our pipeline for predicting novel
lncRNAs from the RNA-Seq data (Figure 1).
Initial assembly
Initial assembly (Figure 1-a) represents a genome-guided
strategy for transcriptome reconstruction [23]. The raw
RNA-Seq reads were ﬁrst mapped onto the mm9 genome
by Tophat 2.0.3 [19]. After that, the un-mapped reads were
trimmed to 50 nt before re-mapping. The ﬁnal mapped
reads of each replicate include two parts, namely ‘Mapped
reads 1’ and ‘Mapped reads 2’. Moreover, the ‘-G’ option
of Tophat together with the Gene Transfer Format (GTF)
ﬁle of the Ensembl gene annotation was used for read
mapping. With the read alignments, we calculated the
overlap ratio (OR) between the replicates of each condi-
tion (Additional ﬁle 1). To increase the read coverage, we
merged the read alignments of all six replicates into one
Binary version of Sequence Alingment/Map (BAM) using
Samtools 0.1.18 [37]. Then the mapped reads were assem-
bled by Cuﬄinks 2.0.2 [21]. In the transcriptome assembly,
we performed Reference Annotation Based Transcript
(RABT) assembly [38] with the RefSeq gene annota-
tion to compensate incompletely assembled transcripts
caused by read coverage gaps in the regions of RefSeq
genes.
Novel lncRNAs detection
Novel lncRNAs detection (Figure 1-b) is aimed at detect-
ing novel lncRNAs from the initial assemblies. Speciﬁ-
cally, the initial assemblies were ﬁrst compared to a set
of combined gene annotations (See below) using cuﬀ-
compare [22]. As a result, not only the assemblies that
completely match the annotations will be detected, but
also the novel transcripts can be categorized into diﬀer-
ent categories according to their locations compared with
the reference genes. Notably, only multi-exon transcripts
were retained for the comparison and downstream pro-
cessing. Then low-quality assemblies were ﬁltered accord-
ing to the optimum Fragments Per Kilobases of exon
per Million fragments mapped (FPKM) [21] threshold
(2.12, see below). After that, we used a newly-developed
program called lncRScan (See below) to detect novel
lncRNAs.
Combined gene annotations of RefSeq, Ensembl and UCSC
mouse known genes
The cuﬀcompare program [22] was used to merge the
RefSeq, Ensembl and UCSC mouse known genes into
one set of gene annotation for comparing with the
assembled transcripts.
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Figure 1 Pipeline for predicting novel lncRNAs. (a) Initial assembly. Raw reads are ﬁrst mapped onto the reference mouse genome. The
un-mapped reads are trimmed before re-mapping. Merging the read alignments of all 6 replicates is to increase the read coverage. At the assembly
stage, RABT generates synthetic reads from the RefSeq gene annotation to compensate the read coverage gaps over transcripts; (b) Novel lncRNAs
detection. The initial assemblies are categorized by cuﬀcompare, compared with the combined gene annotations. The low-quality transcripts are
then ﬁltered according to the optimum FPKM (2.12). The lncRScan program is performed to detect the novel lncRNAs from the remaining
high-quality assemblies according to multiple criteria.
FPKM threshold for classifying complete and partial
transcripts
Based on the merged read alignments, we conducted an
experiment to evaluate the performance of FPKM in clas-
sifying complete and partial transcripts. Speciﬁcally, we
ﬁrst ran cuﬄinks on the merged read alignments with
default options. Then the output assemblies with FPKM
values estimated were categorized using cuﬀcompare,
compared with the combined gene annotations. With the
results, we evaluated the performance of diﬀerent FPKM
thresholds in classifying the complete and partial tran-
scripts by ReceiverOperating Characteristic (ROC) [39].
Calculating optimum FPKM threshold
The optimum FPKM threshold for classifying the com-
plete and partial transcripts were calculated by train-
ing the FPKM values estimated from the experiment
above. The index of the optimum FPKM threshold can
be obtained by optimizing the sensitivity and speciﬁcity





(1 − sensitivities[ i] )2+(1 − speciﬁcities[ i] )2
}
(1)
where i∗ represents the index of the optimum FPKM
threshold. On the right of formula 1, sensitivities[ i] and
speciﬁcities[ i] respectively denote the ith sensitivities and
speciﬁcities, given an index i. The i is enumerated in I,
ranging from 1 to the size of a FPKM threshold set. Then
we can get the optimum FPKM threshold using formula 2.
t∗ = T[ i∗] (2)
where t∗ denotes the optimum FPKM threshold. The
FPKM threshold set T were generated by pROC [39],
given the FPKM values of the complete and partial tran-
scripts.
lncRScan
To detect novel lncRNAs from a set of high-quality
assemblies, a ﬁve-step program named long non-coding
RNA Scan (lncRScan) was designed (Figure 2). Step 1
‘extract category’ is used to extract ﬁve candidate cate-
gories of transcripts, including ‘i’, ‘j’, ‘o’, ‘u’ and ‘x’, which
may contain novel lncRNAs. Speciﬁcally, the ‘i’ cate-
gory may contain the lncRNAs falling entirely within an
intron of known genes. And the ‘j’ category may include
alternative long non-coding isoforms of known genes
as they share at least one spliced site with reference
transcripts. The ‘u’ category may involve the intergenic
lncRNAs (lincRNAs). The ‘o’ category may contain the
lncRNAs having generic exonic overlap with a known
transcript while the ‘x’ transcripts also have exonic overlap
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Figure 2 Steps of lncRScan. (1) ‘extract category’ extracts ﬁve
candidate categories of assemblies (Transcripts-1), including ‘i’, ‘j’, ‘o’,
‘u’ and ‘x’; (2) ‘extract length’ is used to extract the transcripts with
length > 200 nt (Transcripts-2); (3) ‘extract ORF’ selects the transcripts
with maximum putative ORF < 300 nt (Transcripts-3); (4)
‘extract PhyloCSF’ extracts the transcripts with PhyloCSF score < 0 or
test failure due to ORF < 25 aa (Transcripts-4); (5) ’extract Pfam’
searches the remaining transcripts in the Pfam database and excludes
the transcripts with signiﬁcant protein domain hits. Towards the end
of lncRScan, the remaining 308 transcripts (Transcripts-5) are deﬁned
as the novel lncRNAs.
with reference but on the opposite strand. Therefore, the
ﬁve categories deﬁned here may include novel lncRNAs
potentially. On the other hand, all categories of tran-
scripts extracted have not been annotated by either of
RefSeq, Ensembl and UCSC known genes, so the pre-
dicted lncRNAs can be ‘novel’. Step 2 ‘extract length’ is
used to extract the transcripts having long exonic length
(> 200 nt) according to the lncRNA’s deﬁnition. Step 3
‘extract ORF’ is set to exclude the assemblies that have
long (≥ 300 nt) putative ORF. Then steps 4 and 5 are
used to exclude the transcripts of protein-coding poten-
tial. In Step 4 ‘extract PhyloCSF’, Phylogenetic Codon
Substitution Frequency (PhyloCSF) [40] is recruited to
ﬁlter the transcripts of protein-coding potential from an
evolutionary view. Brieﬂy, PhyloCSF conducts a com-
parative genomics method for classifying protein-coding
and non-coding sequences [40]. Since the sequence align-
ments are required for running PhyloCSF, we used Galaxy
[41-43] to ‘stitch’ 29 mammalian alignments according to
the input transcripts. In Step 5 ‘extract Pfam’, the amino
acid sequences of the remaining transcripts are searched
in Pfam [44] (both Pfam-A and Pfam-B) for comparing to
known proteins or protein domains, and the transcripts
with signiﬁcant domain hits are excluded.
To evaluate the performance of lncRScan in identify-
ing lncRNAs or ﬁltering mRNAs, we ran the steps 3-5 of
lncRScan on four datasets respectively. The ﬁrst dataset
(D-1) contains 1615 multi-exon RefSeq ncRNAs with
length > 200nt and the second one (D-2) records 1615
mRNAs randomly sampled from 26368 RefSeq mRNAs.
The other two datasets (D-3 and D-4) include 3230 and
4845 mRNAs sampled from the RefSeq mRNAs respec-
tively. The numbers of the retained and ﬁltered transcripts
through the steps 3-5 of lncRScan are summarized in
Table 1. We can see that 771 (47.74%) lncRNAs of D-1
were retained after the steps 3-5. In contrast, most (99.6%-
99.7%) of the mRNAs (D-2, D-3 and D-4) were ﬁltered
by the steps 3-5. The result indicates that the ﬁlters of
lncRScan can dramatically reduce the number of mRNAs.
Notably, the step 3 adopting the ORF threshold can ﬁlter
a large proportion of mRNAs thereby alleviating the over-
load of PhyloCSF and Pfam calculation. However, some
true lncRNAs were ﬁltered through the pipeline, which
made the ﬁnal lncRNAs prediction much stringent.
In addition, lncRScan is available to the scientiﬁc com-
munity and it can be obtained by svn checkout http://
lncrscan.googlecode.com/svn/trunk/lncrscan-read-only.
Other details about lncRScan can be found on http://
code.google.com/p/lncrscan/ .
Diﬀerential expression analysis
The cuﬀdiﬀ [22] program was performed to conduct
diﬀerential expression (DE) tests between the wild-type
(WT) and Klf1 knockout (Klf1 KO) samples (Figure 3).
The fold changes were calculated via log2 FPKMWTFPKM Klf 1KO . A
transcript will be reported DE signiﬁcant if the test gives
that the FDR-adjusted p-value after Benjamini-Hochberg
correction [45] for multiple-testing represent statistical
signiﬁcant (q-value < 0.05) [46].
Comparisons of transcript length, exon number, ORF
length and expression level
The novel lncRNAs we detected were compared to 26368
RefSeq protein-coding transcripts (‘NM’ preﬁx) and 2843
RefSeq non-coding transcripts (‘NR’ preﬁx) in terms of
transcript length, exon number and ORF length. Since a
real ncRNA does not have an ORF, a putative ORF of
the ncRNA candidate is deﬁned by the longest consecu-
tive codon chain of the ncRNA candidate for comparing
with the protein-coding genes. Moreover, for both of the
WT and Klf1 KO conditions, we compared the quanti-
ﬁed expression levels (FPKM) of the novel lncRNAs to
that of the known protein-coding transcripts, which were
extracted from the RefSeq and Ensembl gene annotations.
The novel lncRNAs and protein-coding transcripts used




We started our analysis with short read mapping
(Figure 1-a), and approximately 138 million reads were
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Table 1 Numbers of retained and ﬁltered transcripts through steps 3-5 of lncRScan
Test data extract ORF(Step 3) extract PhyloCSF(Step 4) extract Pfam(Step 5)
Retained Filtered Retained Filtered Retained Filtered
D-1 (1615 lncRNAs) 952(58.95%) 663 813(50.34%) 139 771(47.74%) 42
D-2 (1615 mRNAs) 33(2%) 1582 12(0.74%) 21 6(0.37%) 6
D-3 (3230 mRNAs) 89(2.76%) 3141 45(1.44%) 44 10(0.31%) 35
D-4 (4845 mRNAs) 112(2.31%) 3733 50(1.03%) 62 18(0.37%) 32
successfully mapped onto the mm9 genome (Table 2).
With the merged alignments of six replicates, 34053
multi-exon transcripts (26212 annotated, 701 contained
by annotations and 7140 novel potentially) were assem-
bled in total, compared with 88434 transcripts of the
combined gene annotations. Then we obtained the cat-
egories of the initial assemblies by comparing to the
combined gene annotations (Table 3). It is notable that
the initial assemblies include several categories of tran-
scripts, e.g. transcripts that have complete match intron
chain compared with known genes (‘=’ classcode) and
those contained by known genes (‘c’ classcode). Of the
initial assemblies, 26212 (76.97%) transcripts have been
annotated by either of RefSeq, Ensembl and UCSC known
genes.
Filtering low-quality assemblies with optimum FPKM
threshold
FPKM can unbiasedly represent quantiﬁed expression
level of an assembled transcript, and it can be estimated
bymaximum likelihood estimation (MLE) under a statisti-
cal model of cuﬄinks [21], which also corrects sequencing
biases [18] in the estimation. Figure 4 shows the FPKM
distributions [47] of the complete (‘=’ classcode) and par-
tial (‘c’ classcode) transcripts assembled from the exper-
iment of FPKM threshold (See Methods) while Figure 5
shows the corresponding ROC curve. Notably, the com-
plete transcripts represent much larger FPKM than the
partial ones on average (∼29.67 vs∼4.86, P < 2.2×10−16,
Figure 3 Diﬀerential expression tests. The cuﬀdiﬀ program
performs diﬀerential expression tests between the WT and Klf1 KO
samples based on the read alignments (BAM) of the six replicates and
high-quality assemblies (GTF).
Welch Two Sample t-test). According to the signiﬁcant
diﬀerence of FPKM distributions of complete and partial
assemblies, we calculated the optimum FPKM threshold
(2.12) based on our data (See Methods). We assumed that
the artiﬁcial transcripts represent either similar FPKM
distribution to the partial transcripts or lower FPKM than
the partial ones, thus the optimum threshold can be used
to ﬁlter both of the partial assemblies and artefacts from
the 7140 novel assemblies.
Identiﬁcation of high-quality assemblies
We pooled a set of high-quality assemblies (Additional
ﬁle 2) for downstream analysis. The high-quality assem-
blies consist of two categories. One category contains the
26212 initial assemblies that completely match the com-
bined gene annotations (‘=’ classcode). The other category
refers to the 3288 transcripts extracted from the 7140
novel assemblies (!{‘=’,‘c’}), which satisfy the expression
criterion (FPKM ≥ 2.12).
Novel mouse embryonic lncRNAs
We applied our newly developed lncRNAs detector
lncRScan to the high-quality assemblies and detected 308
novel mouse embryonic lncRNAs (Additional ﬁle 3). The
novel lncRNAs were further classiﬁed into 5 categories
by comparing with the known gene annotations (Table 4).
Speciﬁcally, 52 lncRNAs were assigned the ‘u’ classcode
since they were located in the intergenic regions. And
26 lncRNAs with the ‘i’ classcode fall entirely within
the intron of known genes. The other lncRNAs all have
exon overlap with known genes. Speciﬁcally, 44 lncRNAs
with the ‘o’ classcode have generic exonic overlap with
Table 2 Readmapping summary
Replicate Raw reads Un-mapped Mapped
KO 1 25153995 5713351 (22.7%) 19440644 (77.3%)
KO 2 26269828 3294901 (12.5%) 22974927 (87.5%)
KO 3 25988788 6032342 (23.2%) 19956446 (76.8%)
WT 1 20034326 2006957 (10.0%) 18027369 (90.0%)
WT 2 22221706 4486281 (20.2%) 17735425 (79.8%)
WT 3 45034903 4678496 (10.4%) 40356407 (89.6%)
total 164703546 26212328 (15.9%) 138491218 (84.1%)
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Table 3 Categories of initial assemblies
Class code Transcript number Percentage Description
= 26212 76.97% Complete match of intron chain
c 701 2.06% Contained by a reference transcript
j 6207 18.23% At least one splice junction is shared with a reference transcript
i 155 0.46% A transfrag falling entirely within a reference intron
o 187 0.55% Generic exonic overlap with a reference transcript
u 492 1.44% Unknown, intergenic transcript
x 98 0.29% Exonic overlap with reference on the opposite strand
s 1 0.00% An intron of the transfrag overlaps a reference intron on the oppo-
site strand
total 34053 100% Total
known genes and 6 ‘x’ lncRNAs also have exonic over-
lap with known genes but on the opposite strand. The
180 lncRNAs with ‘j’ can be long non-coding isoforms
of known genes. In addition, the 308 novel lncRNAs we
predicted were compared with 36991 ones annotated by
NONCODE 3.0 [48]. Of the 308 novel lncRNAs, 5 (1.62%)
ones have the same structure as NONCODE lncRNAs
(Additional ﬁle 1) and another 75 (24.35%) ones partially
overlap the NONCODE lncRNAs (Figure 6). By excluding
the 80 lncRNAs that overlap the NONCODE annotation,
we can get a more stringent set of novel lncRNAs.
Novel lncRNAs have shorter transcript length, fewer exons
and shorter putative ORF than protein-coding transcripts
Previous studies in mammals have shown that lncR-
NAs are shorter in length and fewer in exon number
than are protein-coding transcripts [13,14,16]. To deter-
mine whether the embryonic lncRNAs we detected have
the same features, we compared the 308 novel lncRNAs
to not only 26368 protein-coding transcripts, but also
2843 known non-coding ones, annotated by RefSeq (See
Methods). As shown in Figure 7, the novel lncRNAs
represent much shorter transcript length on average
than either RefSeq protein-coding (∼1.2kb vs ∼3.1kb,
P < 2.2 × 10−16,Welch Two Sample t-test) or non-coding
transcripts (∼1.2kb vs ∼1.9kb, P = 6.027 × 10−14) while
the lncRNAs also show fewer exons than either of the Ref-
Seq protein-coding (∼2.8 vs ∼10.0, P < 2.2 × 10−16) and
non-coding transcripts (∼2.8 vs ∼3.3, P = 5.096 × 10−8),
agreed with a previous report [13]. In addition, we also
compared the putative ORF lengths of the lncRNAs to
that of the RefSeq genes (both protein-coding and non-
coding). As a result, the novel lncRNAs represent shorter
putative ORF length than either RefSeq protein-coding
RNAs (∼0.17 kb vs ∼1.6 kb, P < 2.2 × 10−16) or














Figure 4 FPKM distributions of complete and partial transcripts. The ‘=’ classcode is originally assigned to the transcripts that have complete
match intron chain with a reference transcript and they can be treated as complete transcripts while the ‘c’ classcode is attached to the transcripts
contained by reference and they are deﬁned as partial assemblies. The complete (‘=’, red curve) and partial (‘c’, blue curve) transcripts assembled
from the read alignments represent distinguishable FPKM distributions from each other (∼29.67 vs ∼4.86).
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Figure 5 Performance of FPKM in distinguishing between
complete and partial transcripts. An assembled transcript will be
classiﬁed into the category of complete assemblies (‘=’ classcode) if
its FPKM is larger than a given threshold, otherwise it will be put into
the partial category (‘c’ classcode). The blue ROC curve [39] represents
the performance of FPKM in classifying the complete and partial
transcripts. The corresponding Area Under Curve (AOC) is 0.7825.
consistent with a previous report on zebraﬁsh embry-
onic lncRNAs [16]. Although the novel lncRNAs candi-
dates are to be ncRNAs, they can diﬀer from the RefSeq
ncRNAs used for comparison in some features due to
several reasons as follows. First, the RefSeq ncRNAs do
not only include lncRNAs, but also other categories of
ncRNAs, e.g. microRNAs and small nucleolar RNAs. Sec-
ond, the lncRNAs can be further classiﬁed according to
their biological functions, thus the features of diﬀerent
categories of lncRNAs may diﬀer from each other. The
lncRNAs we detected may not come from the same cate-
gory as that annotated by RefSeq. Third, the unbalanced
population sizes can aﬀect the comparison between the
two categories of ncRNAs. Last, the putative ORF length
of the lncRNAs we predicted were limited (< 300 nt),
which can aﬀect the ORF comparison. Therefore it is
reasonable to see that the two categories of ncRNAs repre-
sent slight statistical diﬀerence, which is far less than that
between the mRNAs and ncRNAs.
Novel lincRNAs have lower expression level than
protein-coding transcripts
Previous studies also showed that lncRNAs are expressed
at signiﬁcantly lower levels than are protein-coding tran-
scripts [13,14,16]. To determine whether the embryonic
lncRNAs we detected have the same expression feature,
we compared the quantiﬁed expression levels (FPKM) of
the 308 novel lncRNAs to that of the known protein-
coding transcripts (Figure 8). In the WT condition
(Figure 8-a), the protein-coding transcripts represents
slightly higher expression than the novel lncRNAs on
average (∼50.92 vs ∼44.54, P = 0.554, Welch Two Sam-
ple t-test). Similarly, in the Klf1 KO condition (Figure 8-b),
the protein-coding transcripts also show slightly higher
expression than the lncRNAs on average (∼37.63 vs
∼34.06, P = 0.6986). The comparison result indicates
that the total novel lncRNAs do not show signiﬁcant
lower expression than the protein-coding ones. Moreover,
we extracted the 52 lincRNAs (‘u’ classcode) from the
308 lncRNAs for the expression comparison. The result
manifests that the lincRNAs we predicted represents sig-
niﬁcant lower expression than the protein-coding ones
in either WT or Klf1 KO condition (∼11.29 vs ∼50.93,
P < 2.2 × 10−16, and ∼9.38 vs ∼37.63, P < 2.2 × 10−16,
respectively).
Diﬀerentially expressed lncRNAs
Using cuﬀdiﬀ, we conducted the diﬀerential expression
(DE) tests between the WT and Klf1 KO samples for
analysing the function of the novel lncRNAs. At the gene
level (Figure 9-a), Klf1 represents like an activator since
more assembled genes are signiﬁcantly repressed (334)
after Klf1 is knocked out than the activated ones (250). At
the transcript level (Figure 9-b), Klf1 also behaves like an
activator sincemore transcripts are signiﬁcantly repressed
(262) after Klf1 is knocked out than the activated ones
(147). Moreover, we detected 13 (Additional ﬁle 4) novel
lncRNAs with DE signiﬁcant. Notably, Klf1 still functions
like an activator for the 13 lncRNAs (10 repressed vs 3
activated after Klf1 is knocked out, Figure 9-c). Thus it
Table 4 Categories of novel lncRNAs
Class code Transcript number Percentage Description
j 180 58.44% At least one splice junction is shared with a reference transcript
i 26 8.44% A transfrag falling entirely within a reference intron
o 44 14.29% Generic exonic overlap with a reference transcript
u 52 16.88% Unknown, intergenic transcript
x 6 1.95% Exonic overlap with reference on the opposite strand
total 308 100% Total
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Figure 6 Comparison between novel lncRNAs and NONCODE lncRNAs. There are 36991 lncRNAs annotated by NONCODE 3.0 and 308 lncRNAs
predicted by our method. Of the 80 (25.97% of our prediction) overlapped lncRNAs, 5 ones have been exactly annotated by NONCODE 3.0.
is obvious that Klf1 can function as an activator globally,
regulating the expression of a number of genes or tran-
scripts including the lncRNAs we detected. The detailed
categories of the 13 lncRNAs of DE signiﬁcant can be seen
from Table 5.
However, cuﬀdiﬀ does a length correction that has a ten-
dency to inﬂate the FPKM counts for small transcripts,
which can interfere the diﬀerential expression analysis. To
alleviate this problem, we re-ran the DE tests with the “–
no-eﬀective-length-correction”parameter. As a result, we




























































































Figure 7 Comparisons of transcript length, exon number and ORF length. (a) Comparison of transcript length. The novel lncRNAs show
shorter length (∼1.2kb) on average than either RefSeq protein-coding (∼3.1kb) or non-coding transcripts (∼1.9kb); (b) Comparison of exon
number. The lncRNAs represent fewer exons (∼2.8) than the other two categories of transcripts (∼10.0 and ∼3.3, respectively) on average; (c)
Comparison of ORF length. The novel lncRNAs show shorter putative ORF length (∼0.17kb) than either of the two RefSeq gene categories (∼1.6kb
and ∼0.3kb, respectively) on average. All means are marked by red points.
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Figure 8 Comparison of expression level between protein-coding transcripts and novel lncRNAs. (a) In the WT condition, the protein-coding
transcripts (∼50.92) represent slightly higher expression level than the novel lncRNAs (∼44.54), but signiﬁcantly higher expression than the lincRNAs
(∼11.29) extracted from the lncRNAs; (b) In the Klf1 KO condition, the protein-coding transcripts (∼37.63) also show slightly higher expression level
than the lncRNAs (∼34.06), but signiﬁcantly higher expression than the lincRNAs (∼9.6). In addition, the protein-coding transcripts and the novel
lncRNAs represent similar median expression in either WT (10.29 vs 9.509) or Klf1 KO (9.421 vs 7.722) condition. All means are marked by red points.
obtained the same results as that without the parameter,
which represent the robustness of our predictions.
Discussion
RNA-Seq has been revolutionizing the transcriptome
study as it can eﬀectively capture the whole transcrip-
tome of various cell types under diﬀerent conditions.
Here we predicted 308 novel mouse embryonic lncRNAs
from the RNA-Seq data of WT and Klf1 KO samples
using a computational pipeline. The novel lncRNAs we
detected represent shorter transcript length, fewer exons
and shorter putative ORF length, and the 52 lincRNAs of
the lncRNAs show lower expression level, compared with
known protein-coding transcripts. Moreover, we iden-
tiﬁed 13 diﬀerentially expressed novel lncRNAs, which
may be regulated by Klf1 and play functional roles in the
development of erythroid cells potentially. Notably, two
lncRNAs (IDs: 2 00016377 and 2 00016378) we predicted
(a) (b) (c)
Figure 9 Diﬀerential expression of transcripts betweenWT and Klf1 KO. The three volcano plots illustrate the diﬀerential expression (DE)
between the WT and Klf1 KO samples at either gene or transcript level: (a) DE of all genes. At the gene level, Klf1 globally appears to be an activator
since more genes are signiﬁcantly repressed (334, red points over the positive x-axis) than the activated ones (250, red points over the negative
x-axis) after Klf1 is knocked out; (b) DE of all transcripts. At the transcript/isoform level, Klf1 also behaves like an activator since more transcripts are
signiﬁcantly repressed (262) than activated ones (147) after Klf1 is knocked out; (c) DE of the novel lncRNAs. For the 13 DE signiﬁcant lncRNA
transcripts, Klf1 still functions like an activator since 10 lncRNAs are repressed and 3 ones are activated after Klf1 is knocked out. The DE signiﬁcant
transcripts are all represented by red points.
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Table 5 Categories of novel lncRNAs of diﬀerential expression signiﬁcant
Class code Transcript number Percentage Description
j 5 38.46% At least one splice junction is shared with a reference transcript
i 1 7.69% A transfrag falling entirely within a reference intron
o 2 15.38% Generic exonic overlap with a reference transcript
u 4 30.77% Unknown, intergenic transcript
x 1 7.69% Exonic overlap with reference on the opposite strand
total 13 100% Total
represent almost the same structures as another two
lncRNAs predicted by Tallack et al. [27] based on the
same dataset. Speciﬁcally, most exons of 2 00016377
and 2 00016378 match that of their ‘lincred1-giant’ and
‘lincred1-dwarf ’ lncRNAs respectively. The slight diﬀer-
ence may be caused by both of the strategies of transcrip-
tome reconstruction and program versions used. Despite
of that, the diﬀerential expression of the two lncRNAs
we detected can be explained by Tallack et al.’s valida-
tion using Real-time Quantitative PCR (qRT-PCR) [49]
on their ‘lincred1’ lncRNAs.
On the other hand, our pipeline followed a similar strat-
egy for predicting human lincRNAs [13], but we diﬀer in
three aspects. First, we used FPKM as a feature for ﬁl-
tering low quality assemblies instead of the read coverage
[13] due to the fact that FPKM can unbiasedly represent
the expression level of a transcript and the read coverage
does not show better performance than FPKM in classi-
fying the complete and partial transcripts assembled from
our data (AUCs are equal). Second, we excluded the tran-
scripts having long putative ORF length (≥ 300 nt), which
was previously used by the FANTOM consortium [50].
This arbitrary cutoﬀ makes our predictions more strin-
gent, but it must omit the lncRNAs having long putative
ORF (≥ 300 nt). Last, we detected several DE signif-
icant lncRNAs, which composed a subset of the total
lncRNAs we detected and they are more worth being
investigated by loss and gain of function studies than the
other novel lncRNAs in our scenario. Consequently, our
computational methods can eﬀectively alleviate further
experimental work for studying the lncRNAs that may
participate in the development of erythroid cells.
Although our method presented its ability in detect-
ing novel lncRNA candidates, its prediction accuracy can
be improved from several aspects, such as using more
reliable reads generated by high-quality deep sequencing,
paired-end sequencing and strand-speciﬁc sequencing.
And recent single-molecule sequencing technologies can
provide more unbiased ways to capture the transcrip-
tome [51]. The sensitivity of transcriptome reconstruc-
tion can also be improved by using various strategies,
such as integrating assembly results from Scripture [14].
In addition, the novel lncRNAs predicted from our
computational pipeline should be validated by biological
experiments, such as cloning and PCR-based techniques
[22] as several ones have been tested in the original
study by Tallack et al. [27]. Furthermore, additional
genetic and/or epigenetic data sources, e.g. Chromatin
Immunoprecipitation-Sequencing (ChIP-Seq) on chro-
matin signatures, can be valuable sources providing use-
ful information for characterizing functions of the novel
lncRNAs. And the loss and gain of function studies can
be conducted for exploring regulatory mechanisms of the
lncRNAs.
Conclusions
We predicted a set of novel lncRNAs using our computa-
tional pipeline from the RNA-Seq data of Klf1 knockout
study, and the DE signiﬁcant lncRNAs are worth being
further studied with regard to their biological functions.
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